Molecular Mechanisms of Cell Death
细胞死亡的分子机制
基本信息
- 批准号:MC_UU_00025/4
- 负责人:
- 金额:$ 396.02万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Intramural
- 财政年份:2018
- 资助国家:英国
- 起止时间:2018 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Diseases such as cancer and neurodegenerative disorders are characterised by a significant alteration in the total number of cells within the tissue. This may result from increased division of cells and/or may arise from a defect in cell death regulation. In tissues, such as the lymphoid system or the colon, cell death is very important as it controls the total number of cells within that tissue, whereas in the nervous system inappropriate cell death is catastrophic. Consequently, cell death in these situations is tightly controlled and often occurs in an ordered manner by a process called ‘apoptosis’, or a more recently identified mode of cell death termed ‘necroptosis’. We are studying these cell death processes because to successfully treat many diseases (e.g. cancer) it is important that we find ways to switch ‘ON’ cell death. However, it is crucial to first understand the basic mechanisms that regulate cell death in order to identify ways of selectively killing target cells while leaving most healthy cells unharmed. We are therefore trying to understand the fundamental mechanisms that regulate the response of target cells and normal cells to cytotoxic agents, as this will help in establishing the ideal choice agents for the treatment of disease. Our aim is to establish better predictive models of mitochondrial toxicity, providing mechanistic frameworks to facilitate safer drug development and potentially alleviate the toxic effects of existing treatments.
癌症和神经退行性疾病等疾病的特征是组织内细胞总数的显著变化。这可能是由于细胞分裂增加和/或细胞死亡调节的缺陷造成的。在淋巴系统或结肠等组织中,细胞死亡是非常重要的,因为它控制着组织中的细胞总数,而在神经系统中,不适当的细胞死亡是灾难性的。因此,在这些情况下,细胞死亡受到严格的控制,并通常通过一种称为“细胞凋亡”的过程或最近发现的一种称为“坏死性下垂”的细胞死亡模式以有序的方式发生。我们正在研究这些细胞死亡过程,因为要成功治疗许多疾病(例如癌症),重要的是我们要找到打开细胞死亡的方法。然而,首先了解调节细胞死亡的基本机制是至关重要的,这样才能确定选择性杀死靶细胞的方法,同时使大多数健康细胞不受损害。因此,我们正试图了解调控靶细胞和正常细胞对细胞毒剂反应的基本机制,因为这将有助于建立治疗疾病的理想选择药物。我们的目标是建立更好的线粒体毒性预测模型,提供机制框架,促进更安全的药物开发,并潜在地减轻现有治疗方法的毒性影响。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Characterisation of FADD interactome reveals novel insights into FADD recruitment and signalling at the Death Inducing Signalling Complex (DISC)
FADD 相互作用组的表征揭示了对 FADD 招募和死亡诱导信号复合体 (DISC) 信号传导的新见解
- DOI:10.1101/2021.03.25.436271
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Fox J
- 通讯作者:Fox J
Asbestos: Modern Insights for Toxicology in the Era of Engineered Nanomaterials
- DOI:10.1021/acs.chemrestox.8b00146
- 发表时间:2018-10-01
- 期刊:
- 影响因子:4.1
- 作者:Felley-Bosco, Emanuela;MacFarlane, Marion
- 通讯作者:MacFarlane, Marion
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells.
- DOI:10.1038/s41419-023-06240-x
- 发表时间:2023-11-08
- 期刊:
- 影响因子:9
- 作者:Chrisochoidou, Yakinthi;Roy, Rajat;Farahmand, Pooyeh;Gonzalez, Guadalupe;Doig, Jennifer;Krasny, Lukas;Rimmer, Ella F.;Willis, Anne E.;MacFarlane, Marion;Huang, Paul H.;Carragher, Neil O.;Munro, Alison F.;Murphy, Daniel J.;Veselkov, Kirill;Seckl, Michael J.;Moffatt, Miriam F.;Cookson, William O. C.;Pardo, Olivier E.
- 通讯作者:Pardo, Olivier E.
N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis.
- DOI:10.1038/s41419-018-0544-7
- 发表时间:2018-05-01
- 期刊:
- 影响因子:9
- 作者:Estornes Y;Dondelinger Y;Weber K;Bruggeman I;Peall A;MacFarlane M;Lebecque S;Vandenabeele P;Bertrand MJM
- 通讯作者:Bertrand MJM
TAp73 regulates mitochondrial dynamics and multiciliated cell homeostasis through an OPA1 axis
- DOI:10.1101/2023.03.23.533672
- 发表时间:2023-03
- 期刊:
- 影响因子:0
- 作者:Niall Buckley;A. Craxton;Xiao-Ming Sun;Emanuele Panatta;L. Piñón;Jaime Llodrá;N. Morone;I. Amelio;G. Melino;L. Martins;M. MacFarlane
- 通讯作者:Niall Buckley;A. Craxton;Xiao-Ming Sun;Emanuele Panatta;L. Piñón;Jaime Llodrá;N. Morone;I. Amelio;G. Melino;L. Martins;M. MacFarlane
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marion MacFarlane其他文献
Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery
患者来源的外植体(PDEs)作为一种强大的临床前平台,用于抗癌药物和生物标志物的发现
- DOI:
10.1038/s41416-019-0672-6 - 发表时间:
2020-01-02 - 期刊:
- 影响因子:6.800
- 作者:
Ian R. Powley;Meeta Patel;Gareth Miles;Howard Pringle;Lynne Howells;Anne Thomas;Catherine Kettleborough;Justin Bryans;Tim Hammonds;Marion MacFarlane;Catrin Pritchard - 通讯作者:
Catrin Pritchard
Cysteine conjugate beta-lyase of rat kidney cytosol: characterization, immunocytochemical localization, and correlation with hexachlorobutadiene nephrotoxicity.
大鼠肾细胞质的半胱氨酸缀合物 β-裂解酶:表征、免疫细胞化学定位以及与六氯丁二烯肾毒性的相关性。
- DOI:
- 发表时间:
1989 - 期刊:
- 影响因子:3.8
- 作者:
Marion MacFarlane;John R. Foster;G.Gordon Gibson;Laurence J. King;Edward A. Lock - 通讯作者:
Edward A. Lock
Macrophage-mediated clearance of cells undergoing caspase-3-independent death
巨噬细胞介导的 caspase-3 依赖性死亡细胞清除
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:12.4
- 作者:
C. Turner;A. Devitt;Kate Parker;Marion MacFarlane;M. Giuliano;Gerald M. Cohen;Christopher D. Gregory - 通讯作者:
Christopher D. Gregory
Doxorubicin synergises with a TRAIL-R1-specific ligand to selectively target TRAIL-resistant breast tumour cells for apoptosis
- DOI:
10.1016/j.tox.2011.09.071 - 发表时间:
2011-12-18 - 期刊:
- 影响因子:
- 作者:
Shambhavi Naik;Davina Twiddy;Roshna Mistry;Jennifer M. Edwards;Gerald M. Cohen;Rosemary A. Walker;Marion MacFarlane - 通讯作者:
Marion MacFarlane
The Discovery of Small Molecule Inhibitors of cFLIP that Sensitise Tumour Cells to TRAIL
发现使肿瘤细胞对 TRAIL 敏感的 cFLIP 小分子抑制剂
- DOI:
10.1101/2024.04.22.590574 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Gilda Giancotti;R. French;Olivia Hayward;Kok Yung Lee;Timothy Robinson;Andreia M. Ribeiro da Silva;Athina Varnava;Marion MacFarlane;R. Clarkson;Andrew D. Westwell;Andrea Brancale - 通讯作者:
Andrea Brancale
Marion MacFarlane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marion MacFarlane', 18)}}的其他基金
Mechanisms of Fibre Toxicity (cross-Unit project)
纤维毒性机制(跨单位项目)
- 批准号:
MC_UU_00025/5 - 财政年份:2018
- 资助金额:
$ 396.02万 - 项目类别:
Intramural
相似国自然基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
- 批准号:W2433169
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金项目
相似海外基金
DryBrain: single cell-resolution molecular mechanisms ensuring tolerance of insect nervous system to complete desiccation
DryBrain:单细胞分辨率分子机制确保昆虫神经系统对完全干燥的耐受性
- 批准号:
23K26919 - 财政年份:2024
- 资助金额:
$ 396.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
BRC-BIO: Investigating the molecular mechanisms of fungal cell fusion
BRC-BIO:研究真菌细胞融合的分子机制
- 批准号:
2233325 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
Standard Grant
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
- 批准号:
10656861 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
Elucidation of molecular mechanisms of immune cell differentiation of a novel Rab protein in hematopoietic stem cells
阐明造血干细胞中新型Rab蛋白免疫细胞分化的分子机制
- 批准号:
23K16122 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular Mechanisms of TOX-mediated Programming of CD8 T Cell Exhaustion
TOX 介导的 CD8 T 细胞耗竭编程的分子机制
- 批准号:
10606385 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
Elucidation of molecular mechanisms underlying the flexibility of the comprehensive maintenance system of mature cell functions.
阐明成熟细胞功能综合维持系统灵活性的分子机制。
- 批准号:
23K05742 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms underlying T cell resistance to PD-1 signaling
T 细胞抵抗 PD-1 信号传导的分子机制
- 批准号:
10714460 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
CAREER: Molecular mechanisms of pH sensitive proteins, pathways, and cell behaviors
职业:pH 敏感蛋白的分子机制、通路和细胞行为
- 批准号:
2238694 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
Continuing Grant
Dynamic molecular and cellular mechanisms driving epithelial cell ingression
驱动上皮细胞侵入的动态分子和细胞机制
- 批准号:
480252 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
Operating Grants
Molecular mechanisms of the co-obligate endosymbiosis in aphids at the single-cell level
单细胞水平上蚜虫共专性内共生的分子机制
- 批准号:
23K19389 - 财政年份:2023
- 资助金额:
$ 396.02万 - 项目类别:
Grant-in-Aid for Research Activity Start-up